Ken Griffin
IMCR icon

Ken Griffin’s Immunocore IMCR Stock Holding History

Ken Griffin’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.95M Sell
230,399
-3,869
-2% -$125K ﹤0.01% 3821
2025
Q4 		$8.13M Buy
234,268
+192,070
+455% +$6.78M ﹤0.01% 3529
2025
Q3 		$1.53M Sell
42,198
-162,019
-79% -$5.5M ﹤0.01% 6618
2025
Q2 		$6.41M Buy
204,217
+150,581
+281% +$4.68M ﹤0.01% 3702
2025
Q1 		$1.59M Sell
53,636
-22,034
-29% -$661K ﹤0.01% 5976
2024
Q4 		$2.23M Buy
75,670
+16,562
+28% +$524K ﹤0.01% 5400
2024
Q3 		$1.84M Sell
59,108
-169,844
-74% -$6.18M ﹤0.01% 5695
2024
Q2 		$7.76M Buy
228,952
+166,927
+269% +$8.51M ﹤0.01% 3121
2024
Q1 		$4.03M Sell
62,025
-178,331
-74% -$12.2M ﹤0.01% 4287
2023
Q4 		$16.4M Buy
240,356
+68,784
+40% +$3.58M ﹤0.01% 2231
2023
Q3 		$8.9M Buy
171,572
+135,695
+378% +$8.03M ﹤0.01% 2837
2023
Q2 		$2.15M Sell
35,877
-24,445
-41% -$1.4M ﹤0.01% 5028
2023
Q1 		$2.98M Sell
60,322
-139,266
-70% -$7.83M ﹤0.01% 4643
2022
Q4 		$11.4M Sell
199,588
-94,814
-32% -$5.34M ﹤0.01% 2645
2022
Q3 		$13.8M Buy
294,402
+209,902
+248% +$10M ﹤0.01% 2328
2022
Q2 		$3.15M Buy
84,500
+24,774
+41% +$805K ﹤0.01% 4670
2022
Q1 		$1.79M Buy
59,726
+47,603
+393% +$1.2M ﹤0.01% 6336
2021
Q4 		$415K Sell
12,123
-10,405
-46% -$377K ﹤0.01% 10117
2021
Q3 		$835K Sell
22,528
-28,782
-56% -$971K ﹤0.01% 8589
2021
Q2 		$2M Sell
51,310
-126
-0.2% -$4.86K ﹤0.01% 6616
2021
Q1 		$2.19M Buy
+51,436
New +$2.29M ﹤0.01% 6181

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Ken Griffin's IMCR Position: Q1 2026 in Review

Ken Griffin reduced its Immunocore (IMCR) stake by 1.7% in Q1 2026, selling an estimated $125K and leaving 230,399 shares worth $6.95M. The position accounts for ﹤0.01% of the portfolio, ranked #3821.

Ken Griffin first reported a position in IMCR in Q1 2021 and has held it in 21 quarters since. The position peaked at $16.4M in Q4 2023. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • Ken Griffin held 230,399 shares of Immunocore worth $6.95M as of Q1 2026.
  • Ken Griffin sold 3,869 Immunocore shares in Q1 2026, an estimated $125K.
  • Immunocore made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #3821 holding.
  • Ken Griffin first reported a position in Immunocore in Q1 2021 and has held it in 21 quarters since.
  • Ken Griffin's Immunocore position peaked at $16.4M in Q4 2023.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.